-
International Journal of Chronic Obstructive Pulmonary Disease
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Pathophysiology of viral-induced exacerbations of COPD
(2617) Views (466) Full article downloads
Authors: Potena Alfredo, Caramori Gaetano, Casolari Paolo, Contoli Marco, Sebastian L Johnston, et al
Published Date January 2007
Volume 2007:2(4) Pages 477 - 483
DOI: http://dx.doi.org/10.2147/COPD.S
Potena Alfredo1, Caramori Gaetano2, Casolari Paolo2, Contoli Marco2, Sebastian L Johnston3, Papi Alberto2
1Unità Operativa di Fisiopatologia Respiratoria, Azienda Ospedaliera Universitaria Arcispedale S. Anna, Ferrara, Italy; 2Clinica Pneumologica, Università di Ferrara, Azienda Ospedaliera Universitaria Arcispedale S. Anna, Ferrara, Italy; 3Department of Respiratory Medicine, National Heart and Lung at Wright Fleming Institute of Infection and Immunity, Imperial College London, London, UK
Abstract: Inflammation of the lower airways is a central feature of chronic obstructive pulmonary disease (COPD). Inflammatory responses are associated with an increased expression of a cascade of proteins including cytokines, chemokines, growth factors, enzymes, adhesion molecules and receptors. In most cases the increased expression of these proteins is the result of enhanced gene transcription: many of these genes are not expressed in normal cells under resting conditions but they are induced in the inflammatory process in a cell-specific manner. Transcription factors regulate the expression of many pro-inflammatory genes and play a key role in the pathogenesis of airway inflammation. Many studies have suggested a role for viral infections as a causative agent of COPD exacerbations. In this review we will focus our attention on the relationship between common respiratory viral infections and the molecular and inflammatory mechanisms that lead to COPD exacerbation.
- Journal Indexing
See where all the Dove Press journals are indexed
- Testimonials
"You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio
- Clinical effectiveness of the Respimat® inhaler device in managing chronic obstructive pulmonary disease: evidence when compared with other handheld inhaler devices
- Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity
- The pathophysiology of bronchiectasis
- Exacerbation rate, health status and mortality in COPD – a review of potential interventions




